[HTML][HTML] Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support
OW Press, JF Eary, FR Appelbaum… - … England Journal of …, 1993 - Mass Medical Soc
Background Radiolabeled monoclonal antibodies recognizing B-lymphocyte surface
antigens represent a potentially effective new therapy for lymphomas. We assessed the …
antigens represent a potentially effective new therapy for lymphomas. We assessed the …
Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans
BP Rubin, SM Schuetze, JF Eary… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: Dermatofibrosarcoma protuberans is caused by activation of the platelet-derived
growth factor B (PDGFB) receptor, a transmembrane tyrosine kinase. We investigated the …
growth factor B (PDGFB) receptor, a transmembrane tyrosine kinase. We investigated the …
[18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors
…, CB Vernon, EU Conrad III, JF Eary - Journal of Clinical …, 2005 - ascopubs.org
Purpose Response to neoadjuvant chemotherapy is a significant prognostic factor for the
Ewing sarcoma family of tumors (ESFTs). [ 18 F]fluorodeoxyglucose (FDG) positron emission …
Ewing sarcoma family of tumors (ESFTs). [ 18 F]fluorodeoxyglucose (FDG) positron emission …
[PDF][PDF] Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial
C Collins, JF Eary, G Donaldson… - Journal of Nuclear …, 1993 - Soc Nuclear Med
All patients were treated in single rooms with appropriate shielding to minimize exposure of
health care personnel. The †53Sm-EDTMPwas infused over 30 min by an infusion pump …
health care personnel. The †53Sm-EDTMPwas infused over 30 min by an infusion pump …
Phase I Study of 131I-Anti-CD45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome
DC Matthews, FR Appelbaum, JF Eary… - Blood, The Journal …, 1999 - ashpublications.org
Delivery of targeted hematopoietic irradiation using radiolabeled monoclonal antibody may
improve the outcome of marrow transplantation for advanced acute leukemia by decreasing …
improve the outcome of marrow transplantation for advanced acute leukemia by decreasing …
Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody.
OW Press, JF Eary, CC Badger, PJ Martin… - Journal of clinical …, 1989 - ascopubs.org
The biodistribution, toxicity, and therapeutic potential of anti-CD37 monoclonal antibody (MoAb)
MB-1 labeled with iodine 131 (131I) was evaluated in ten patients with advanced-, low- …
MB-1 labeled with iodine 131 (131I) was evaluated in ten patients with advanced-, low- …
Samarium-153-EDTMP biodistribution and dosimetry estimation.
JF Eary, C Collins, M Stabin, C Vernon… - Journal of Nuclear …, 1993 - europepmc.org
A comment on this article appears in" Samarium-153-EDTMP dosimetry." J Nucl Med. 1994
Jan; 35 (1): 191-2. A comment on this article appears in" Biodistribution and dosimetry of …
Jan; 35 (1): 191-2. A comment on this article appears in" Biodistribution and dosimetry of …
Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma
…, DR Byrd, LK Dunnwald, JF Eary… - … Journal of the …, 2000 - Wiley Online Library
BACKGROUND Sentinel lymph node dissection (SLND) has been a promising new
technique in breast carcinoma staging, but could be unreliable in certain patient subsets. The …
technique in breast carcinoma staging, but could be unreliable in certain patient subsets. The …
Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome
JF Eary, F O'Sullivan, J O'Sullivan… - Journal of Nuclear …, 2008 - Soc Nuclear Med
18 F-FDG PET images of tumors often display highly heterogeneous spatial distribution of 18
F-FDG–positive pixels. We proposed that this heterogeneity in 18 F-FDG spatial distribution …
F-FDG–positive pixels. We proposed that this heterogeneity in 18 F-FDG spatial distribution …
A phase I/II trial of iodine-131–tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas
OW Press, JF Eary, T Gooley, AK Gopal… - Blood, The Journal …, 2000 - ashpublications.org
Relapsed B-cell lymphomas are incurable with conventional chemotherapy and radiation
therapy, although a fraction of patients can be cured with high-dose chemoradiotherapy and …
therapy, although a fraction of patients can be cured with high-dose chemoradiotherapy and …